5-13886135-CAAAAAAAAAA-CAAAAAAAAAAA
Variant names:
Variant summary
Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1
The NM_001369.3(DNAH5):c.2578-7dupT variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.021 ( 65 hom., cov: 0)
Exomes 𝑓: 0.019 ( 8 hom. )
Consequence
DNAH5
NM_001369.3 splice_region, intron
NM_001369.3 splice_region, intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.0110
Publications
2 publications found
Genes affected
DNAH5 (HGNC:2950): (dynein axonemal heavy chain 5) This gene encodes a dynein protein, which is part of a microtubule-associated motor protein complex consisting of heavy, light, and intermediate chains. This protein is an axonemal heavy chain dynein. It functions as a force-generating protein with ATPase activity, whereby the release of ADP is thought to produce the force-producing power stroke. Mutations in this gene cause primary ciliary dyskinesia type 3, as well as Kartagener syndrome, which are both diseases due to ciliary defects. [provided by RefSeq, Oct 2009]
DNAH5 Gene-Disease associations (from GenCC):
- primary ciliary dyskinesia 3Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, ClinGen, Labcorp Genetics (formerly Invitae)
- primary ciliary dyskinesiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -16 ACMG points.
BP6
Variant 5-13886135-C-CA is Benign according to our data. Variant chr5-13886135-C-CA is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 1269037.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0602 is higher than 0.05.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001369.3. You can select a different transcript below to see updated ACMG assignments.
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| DNAH5 | TSL:1 MANE Select | c.2578-7_2578-6insT | splice_region intron | N/A | ENSP00000265104.4 | Q8TE73 | |||
| DNAH5 | c.2533-7_2533-6insT | splice_region intron | N/A | ENSP00000505288.1 | A0A7P0Z455 | ||||
| DNAH5-AS1 | TSL:4 | n.254-10454_254-10453insA | intron | N/A |
Frequencies
GnomAD3 genomes AF: 0.0209 AC: 2583AN: 123802Hom.: 65 Cov.: 0 show subpopulations
GnomAD3 genomes
AF:
AC:
2583
AN:
123802
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0376 AC: 2316AN: 61536 AF XY: 0.0361 show subpopulations
GnomAD2 exomes
AF:
AC:
2316
AN:
61536
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0188 AC: 22720AN: 1205682Hom.: 8 Cov.: 0 AF XY: 0.0188 AC XY: 11187AN XY: 595948 show subpopulations ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
GnomAD4 exome
AF:
AC:
22720
AN:
1205682
Hom.:
Cov.:
0
AF XY:
AC XY:
11187
AN XY:
595948
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
AC:
1120
AN:
26198
American (AMR)
AF:
AC:
679
AN:
26816
Ashkenazi Jewish (ASJ)
AF:
AC:
456
AN:
20550
East Asian (EAS)
AF:
AC:
1400
AN:
32102
South Asian (SAS)
AF:
AC:
1545
AN:
64432
European-Finnish (FIN)
AF:
AC:
503
AN:
30982
Middle Eastern (MID)
AF:
AC:
81
AN:
3502
European-Non Finnish (NFE)
AF:
AC:
15824
AN:
950776
Other (OTH)
AF:
AC:
1112
AN:
50324
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.298
Heterozygous variant carriers
0
1644
3289
4933
6578
8222
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Variant carriers
0
616
1232
1848
2464
3080
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0209 AC: 2583AN: 123780Hom.: 65 Cov.: 0 AF XY: 0.0206 AC XY: 1211AN XY: 58676 show subpopulations
GnomAD4 genome
AF:
AC:
2583
AN:
123780
Hom.:
Cov.:
0
AF XY:
AC XY:
1211
AN XY:
58676
show subpopulations
African (AFR)
AF:
AC:
2108
AN:
33760
American (AMR)
AF:
AC:
126
AN:
12040
Ashkenazi Jewish (ASJ)
AF:
AC:
16
AN:
3010
East Asian (EAS)
AF:
AC:
39
AN:
3582
South Asian (SAS)
AF:
AC:
63
AN:
3852
European-Finnish (FIN)
AF:
AC:
5
AN:
5988
Middle Eastern (MID)
AF:
AC:
7
AN:
236
European-Non Finnish (NFE)
AF:
AC:
183
AN:
58842
Other (OTH)
AF:
AC:
36
AN:
1658
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
103
206
308
411
514
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
26
52
78
104
130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
ClinVar
ClinVar submissions
View on ClinVar Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
Pathogenic
VUS
Benign
Condition
-
-
2
Primary ciliary dyskinesia (2)
-
-
1
not provided (1)
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.